Nimotuzumab plus paclitaxel and cisplatin as the first line treatment for advanced esophageal squamous cell cancer: A single centre prospective phase <scp>II</scp> trial
2016 · Cancer Science · 47 citations
https://doi.org/10.1111/cas.12894
J
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.0K
Citations
23
h-index
37
i10-index
Jun Jia is an academic researcher from The Second Affiliated Hospital of Bengbu Medical College. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes. The author has an h-index of 23, co-authored 95 publications.
ORCID: 0000-0002-8691-0501Papers by this author
worksApatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study
2020 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-020-62961-5
The characteristics of chronic benzene poisoning in 176 Chinese occupational population cases
2025 · Frontiers in Public Health · 1 citations
https://doi.org/10.3389/fpubh.2024.1498114
Lin28B overexpression in oral cancer cell line and in vitro assays.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0083869.g003
81P A real-world multicenter study of furmonertinib in EGFRex20ins mutant advanced NSCLC patients and related structural insights
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.104240
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat